Analysts Set Mereo BioPharma Group plc (NASDAQ:MREO) PT at $7.83
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) has earned a consensus rating of “Buy” from the seven analysts that are covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average 1-year price objective […]
Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) has earned a consensus rating of “Buy” from the seven analysts that are covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company. The average 1-year price objective […]
